Partech

Partech is a global venture firm with offices in Paris, Berlin, San Francisco, Dakar, and other hubs, covering seed through growth across multiple sectors. The firm has been one of the most consistent European investors for two decades and brings a transatlantic perspective that is unusual among continental European funds. For physician AI and digital health founders building enterprise software or clinical platforms, Partech is a credible name across multiple stages.

The thesis covers enterprise software, fintech, marketplaces, and digital health, with active interest in Health IT, clinical software, AI/ML in healthcare, and platforms that digitise healthcare administration and clinical delivery. Within healthcare, the team prefers software-first companies with strong revenue mechanics and a defensible technical or data moat. Pure biotech, hardware-heavy medical devices, and consumer-only health products are less natural fits than B2B and B2B2C software.

Check sizes vary by stage and fund. The seed fund typically writes one to five million dollars, while the growth fund deploys larger cheques into Series B, C, and beyond. Partech can lead rounds, follow on, and accompany companies from seed through later stages within the same firm, which is unusual in Europe and useful for founders planning multi-round trajectories. Geography is European with strong French, German, and Nordic activity, plus selective US and African investments.

The partner team is large and stage-specialised, supported by platform functions across talent, communications, and US expansion. Diligence is structured and rigorous; expect deep conversations on revenue, market, and competitive dynamics. Decisions are committee-driven, with timelines that are predictable rather than fast.

The most reliable way in is through a portfolio CEO, a European operator-investor, or a corporate finance contact already working with Partech. Cold inbound is read but converts less often than warm routes. When you reach out, identify which Partech fund and partner is right for your stage and sector, since the firm is large enough that getting to the right person matters. Lead with the metrics relevant to your stage: design partner traction at seed, ARR and growth at Series A, scaling and unit economics at Series B and beyond. The right time to engage is one to two quarters before opening a round, with enough time for the team to track your progress. Founders pre-team, pre-product, or with no European or transatlantic ambition may find better fits at smaller specialist funds; founders building serious European digital health software companies will find Partech a credible long-term partner.